U3T-25952-82571
3 vaccinations
1 coded response
7 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 068 / CT
- Registered
- 2021-12-14
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-22
Dose 1 — Moderna
-
2021-04-10
Dose 2 — Moderna
-
2021-12-06
Dose 3 — Moderna
-
2021-12-14
Registered in v-safe
-
2021-12-15
Health check-in — day 7, dose 3Feeling: Good · Headache, Muscle or body aches, Fatigue or tiredness, NauseaAdult check-in
- 2021-12-20
-
2021-12-27
Survey response — day 21, dose 3MedDRA: Cough, Diarrhoea, Headache, Nausea, Oropharyngeal pain, Upper-airway cough syndrome — Feeling: Poor · Be unable to do your normal daily activitiesFree text: Sore throat, post-nasal drip, cough, headache, nausea, diarrheaMedDRA releases: 2024-11 · check-in free text available
- 2022-01-03
- 2022-01-12
- 2022-01-17
- 2022-06-06
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-22 | Moderna | No |
| 2 | 2021-04-10 | Moderna | No |
| 3 | 2021-12-06 | Moderna | No |
Free text
Release 10 — day 21, dose 3
Symptoms: Sore throat, post-nasal drip, cough, headache, nausea, diarrhea
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Diarrhoea | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Nausea | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Upper-airway cough syndrome | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release